Engineers Gate Manager LP Adma Biologics, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $206,597 - $386,246
34,548 Added 87.64%
73,968 $826,000
Q1 2024

May 15, 2024
BUY
$4.4 - $6.74 $173,448 - $265,690
39,420 New
39,420 $260,000
Q2 2021

Aug 16, 2021
SELL
$1.51 - $2.07 $51,596 - $70,731
-34,170 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$1.67 - $2.95 $29,392 - $51,920
-17,600 Reduced 34.0%
34,170 $60,000
Q4 2020

Feb 16, 2021
SELL
$1.8 - $2.56 $900 - $1,280
-500 Reduced 0.96%
51,770 $101,000
Q3 2020

Nov 16, 2020
BUY
$2.04 - $3.74 $106,630 - $195,489
52,270 New
52,270 $125,000

Others Institutions Holding ADMA

# of Institutions
312
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email